Min Hu

Min Hu, Ph.D., is Senior Vice President of Oncology Discovery at Innovent Biologics, bringing over two decades of scientific and leadership experience in oncology and drug research. She previously held key R&D leadership roles at Hengrui Pharma, AstraZeneca and Novartis, advancing several NMEs from drug discovery to product launch. Dr. Hu holds a Ph.D. in Basic Medical Sciences from Purdue University and received the postdoctoral training from Dana Faber Cancer Institute, Harvard Medical School. She has contributed to multiple international patent applications in gene methylation and oncology biomarkers, alongside an extensive publication record spanning cancer biology and therapeutic development.